Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease

Clinical trial NCT00195143 · COMPLETED

Trial details

NCT number: NCT00195143
Sponsor: Neurologix, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2003-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.